Results 91 to 100 of about 8,426 (140)

Targeted FcRn to deliver epitope-optimized RBD confers broad-spectrum mucosal protection against SARS-CoV-2. [PDF]

Mol Ther Nucleic Acids
Chen X, Wu Y, Wang Y, Zhao C, Fang L, Zhu X, Lu J, Gao X, Zhang Z, Li H, Yan Y, Zhou P, Pan X.   +12 more
europepmc   +1 more source

Novel biopharmaceutical strategies: Fc-fusion protein technology. [PDF]

Front Pharmacol
Ding XY, Fan HL, Zhang CM, Wei MX, Lin ZZ, Bai CJ, Wang MY, Zhou HH.   +7 more
europepmc   +1 more source

Hypoproteinemia and Hypogammaglobulinemia Due to a Homozygous FCGRT Mutation. [PDF]

J Clin Immunol
Ala AS, Lo B, Ozen A, Islek A, Tumgor G.
europepmc   +1 more source

B Cells and B Cell Depletion in Autoimmunity and Atherosclerosis. [PDF]

Life (Basel)
Solomon JL, Dubbaka A, Srivastava A, Belilos E, Leon J, Carsons SE, Reiss AB.   +6 more
europepmc   +1 more source

Ontogeny of Placental FcRn Protein During Human and Animal Pregnancy to Inform Developmental Toxicity Testing. [PDF]

Birth Defects Res
Bowman CJ, Breslin WJ, Chen C, Foster W, Hui J, Kusmider B, Laffan S, Myers M, Sivaraman L, Tornesi B, Westmoreland S, DeSesso JM.   +11 more
europepmc   +1 more source

Prospective study of efgartigimod in severe myasthenia gravis exacerbations requiring ventilatory or enteral support. [PDF]

J Neuromuscul Dis
Shelly S, Rosenberg A, Zoabi M, Makhoul S, Ramon-Gonen R, Wolfe GI.   +5 more
europepmc   +1 more source

Broadly Protective Antibody-Like Vaccines Against Highly Pathogenic Coronaviruses. [PDF]

J Med Virol
Helal A, Aljehani ND, Ghazwani A, Alsulaiman RM, Alyami F, Abdulaal WH, Alsharef A, Alghanmi M, Zawawi A, Azhari AA, Almehmadi A, Balula J, Altorki T, Alhabbab RY, Khan MY, Alluhaybi K, Alnami A, Neamatallah T, Abujamel TS, Alfaleh MA, Hashem AM.   +20 more
europepmc   +1 more source

Recaticimab: The First Fc-Engineered PCSK9 Monoclonal Antibody for More Long-Lasting Effect in Lipid Lowering. [PDF]

Drugs
Li S, Gao Y, Zhu CG, Li JJ.
europepmc   +1 more source

Pathogenic properties of myasthenia gravis AChR autoantibodies associate with clinical response to efgartigimod. [PDF]

J Neurol Neurosurg Psychiatry
Khani-Habibabadi F, Verhamme FM, Moshir M, Casneuf T, Rao VTS, Steeland S, Ulrichts P, Pham MC, Nowak RJ, Roy B, O'Connor KC.   +10 more
europepmc   +1 more source